Membranous Nephropathy: Dapagliflozin Treatment Study

We are investigating how dapagliflozin affects immune activity and kidney function in patients with Membranous Nephropathy. This study may help us understand its potential benefits for managing this condition.

1-2 years ≤5 visits Efficacy phase (II)Confirmation phase (III)Post-Trial Drug Access No Placebo Partially Remote Standard Medicines OralInternal MedicineNephrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Forxiga

Forxiga is a medicine that lowers blood sugar in adults with type 2 diabetes and can also help certain heart and kidney conditions.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Dapagliflozin

Dapagliflozin is a substance that helps lower blood sugar in people with type 2 diabetes by causing the kidneys to remove excess glucose in urine.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Brolertix

Daforbis

Dagetia

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Universitaire De Nimes

Nephrology

Milhaud, France

Centre Hospitalier Universitaire De Nice

Nephrology

Nice, France

Sponsor: Centre Hospitalier Universitaire De Nice

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.